← Every applicant
Breckenridge FDA Approvals
17 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TOFACITINIB CITRATENew drugJun 3, 2026TABLET, ORAL |
| DEHYDRATED ALCOHOLNew drugJun 23, 2025SOLUTION, INTRA-ARTERIAL |
| RIVAROXABANNew drugMay 15, 2025TABLET, ORAL |
| DABIGATRAN ETEXILATE MESYLATENew drugDec 19, 2024CAPSULE, ORAL |
| METHADONE HYDROCHLORIDENew drugDec 16, 2024INJECTABLE, INJECTION |
| BENDAMUSTINE HYDROCHLORIDENew drugFeb 14, 2023POWDER, INTRAVENOUS |
| FLUPHENAZINE HYDROCHLORIDENew drugNov 15, 2022TABLET, ORAL |
| TRIAZOLAMNew drugNov 8, 2022TABLET, ORAL |
| CABAZITAXELNew drugJun 23, 2022SOLUTION, INTRAVENOUS |
| AMITRIPTYLINE HYDROCHLORIDENew drugJun 6, 2022TABLET, ORAL |
| TERIFLUNOMIDENew drugSep 24, 2021TABLET, ORAL |
| PENICILLAMINENew drugAug 23, 2021CAPSULE, ORAL |
| APIXABANNew drugJul 26, 2021TABLET, ORAL |
| CARFILZOMIBNew drugJun 11, 2021POWDER, INTRAVENOUS |
| EVEROLIMUSNew drugMay 20, 2021TABLET, ORAL |
| EVEROLIMUSNew drugMar 5, 2021TABLET, ORAL |
| NOREPINEPHRINE BITARTRATENew drugJan 22, 2021INJECTABLE, INJECTION |